Ovid Therapeutic's purpose is to solve intractable medical problems.
Ovid Therapeutics has raised $60.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in March 2026.
Ovid Therapeutics's investors include RA Capital Management, Balyasny Asset Management, Cormorant Asset Management, Janus Henderson Investors, Redmile Group.
Ovid Therapeutics is headquartered in New York, United States.
Ovid Therapeutic's purpose is to solve intractable medical problems.
Ovid Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ovid Therapeutics — Funding & Investors." VCBacked, March 17, 2026, https://www.vcbacked.co/company/ovid-therapeutics. Accessed August 14, 2026.
VCBacked. (2026). Ovid Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/ovid-therapeutics
{{cite web |title=Ovid Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/ovid-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated